In view of the fact that, as the target of PHD3 and FIH, HIF is not only a marker of poor prognosis in HCC [57], but also an important regulator of uncontrolled cell proliferation and neovascularization in tumor [58]. This evidence concerns the gene EGLN3 and hepatocellular carcinoma.